Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer ... - Marketscreener.com
NVIVDelisted Stock | USD 1.38 0.07 5.34% |
Slightly above 55% of InVivo Therapeutics' sophisticated investors are presently thinking to get in. The analysis of current outlook of investing in InVivo Therapeutics Holdings suggests that some traders are interested regarding InVivo Therapeutics' prospects. InVivo Therapeutics' investing sentiment can be driven by a variety of factors including economic data, InVivo Therapeutics' earnings reports, geopolitical events, and overall market trends.
InVivo |
Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer ... Marketscreener.com
Read at news.google.com
InVivo Therapeutics Fundamental Analysis
We analyze InVivo Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InVivo Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InVivo Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
InVivo Therapeutics is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
InVivo Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InVivo Therapeutics stock to make a market-neutral strategy. Peer analysis of InVivo Therapeutics could also be used in its relative valuation, which is a method of valuing InVivo Therapeutics by comparing valuation metrics with similar companies.
Peers
InVivo Therapeutics Related Equities
SABS | SAB Biotherapeutics | 5.43 | ||||
NTRB | Nutriband | 0.98 | ||||
MOLN | Molecular Partners | 0.73 | ||||
ANEB | Anebulo Pharmaceuticals | 0.72 | ||||
ASMB | Assembly Biosciences | 0.20 | ||||
SNTI | Senti Biosciences | 0.36 | ||||
CTMX | CytomX Therapeutics | 0.89 | ||||
NXTC | NextCure | 0.92 | ||||
RZLT | Rezolute | 1.08 | ||||
VRAX | Virax Biolabs | 2.48 | ||||
RNXT | RenovoRx | 3.03 | ||||
SPRO | Spero Therapeutics | 4.35 | ||||
LGVN | Longeveron LLC | 5.10 | ||||
KPRX | Kiora Pharmaceuticals | 5.41 | ||||
HCWB | HCW Biologics | 7.69 | ||||
QNRX | Quoin Pharmaceuticals | 9.59 | ||||
REVB | Revelation Biosciences | 12.20 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |